Wolverine Trading
FRTX

Wolverine Trading’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Wolverine Trading’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32
Closed -$46K – 5239
2016
Q2 		$46K Buy
+32
New +$41.2K ﹤0.01% 3824

Other funds holding FRTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's FRTX Position: Q3 2016 in Review

Wolverine Trading sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2016, closing a stake of 32 shares — an estimated $46K sold.

Wolverine Trading first reported a position in FRTX in Q2 2016 and held it in 1 quarter. The position peaked at $46K in Q2 2016. 36 funds tracked by Wall St. Rank hold FRTX as of Q3 2016.

  • Wolverine Trading reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Wolverine Trading sold 32 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $46K.
  • Wolverine Trading first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
  • Wolverine Trading's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $46K in Q2 2016.
  • 36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Wolverine Trading's 13F filing for Q3 2016, filed 14 Nov 2016.